Inflammation and increased intraocular pressure associated with intravitreal aflibercept 8 mg: A systematic review and meta-analysis

Topic: Aflibercept 8 mg was recently approved for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). The increased intravitreal injection volume and higher drug concentration has raised concerns regarding the potential risks of adverse events. The...

Descrición completa

Detalles Bibliográficos

Principais autores:	Nikoline Skindhøj Rebsdorf, Marie Martine Michaelsen, Natasja Kærmose Ølholm, Suffía Olsen, Celine Lee, Yousif Subhi, Marie Ørskov, Henrik Vorum, Lasse Jørgensen Cehofski
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2025-12-01
Series:	AJO International
Assuntos:	Neovascular age-related macular degeneration nAMD Aflibercept Adverse event Intraocular pressure Intraocular inflammation
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2950253525000838
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!